nach oben

European Journal of Pediatrics

Erschienen in:

01.10.2013 | Original Article

Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants

verfasst von: Gamze Demirel, Istemi Han Celik, Omer Erdeve, Sibel Saygan, Ugur Dilmen, Fuat Emre Canpolat

Erschienen in: European Journal of Pediatrics | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Aim

This study aims to compare the efficacy of orally administered Saccharomyces boulardii versus nystatin in prevention of fungal colonization and invasive fungal infections in very low birth weight infants.

Method

A prospective, randomized comparative study was conducted in preterm infants with a gestational age of ≤32 weeks and birth weight of ≤1,500 g. They were randomized into two groups, to receive S. boulardii or nystatin. Skin and stool cultures were performed for colonization and blood cultures for invasive infections, weekly.

Results

A total of 181 infants were enrolled (S. boulardii group, n = 91; nystatin group, n = 90). Fungal colonization of the skin (15.4 vs 18.9 %, p = 0.532) and the stool (32.2 vs 27 %, p = 0.441) were not different between the probiotic and nystatin groups. Two patients had Candida-positive blood culture in the nystatin group whereas none in the probiotic group. Feeding intolerance, clinical sepsis, and number of sepsis attacks were significantly lower in the probiotics group than in the nystatin group.

Conclusion

Prophylactic S. boulardii supplementation is as effective as nystatin in reducing fungal colonization and invasive fungal infection, more effective in reducing the incidence of clinical sepsis and number of sepsis attacks and has favorable effect on feeding intolerance.

Aydemir C, Oguz SS, Dizdar EA et al (2011) Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonization and invasive fungal infection in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 96(3):F164–F168PubMedCrossRef

Benjamin DK Jr, Stoll BJ, Fanaroff AA et al (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117(1):84–92PubMedCrossRef

Dinleyici EC, Eren M, Yargic ZA et al (2009) Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. AmJTrop Med Hyg 80(6):953–955

Enache-Angoulvant A, Hennequin C (2005) Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41:1559–1568PubMedCrossRef

Ganesan K, Harigopal S, Neal T et al (2009) Prophylactic oral nystatin for preterm babies under 33 weeks’ gestation decreases fungal colonization and invasive fungaemia. Arch Dis Child Fetal Neonatal Ed 94(4):F275–F278PubMedCrossRef

Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27(3):202–209PubMedCrossRef

Hope WW, Castagnola E, Groll AH et al (2012) ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 18(Suppl 7):38–52PubMedCrossRef

Howell A, Isaacs D, Halliday R (2009) Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed 94(6):F429–F433PubMedCrossRef

Jawhara S, Poulain D (2007) Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis. Med Mycol 45(8):691–700PubMedCrossRef

10.

Kaufman D, Boyle R, Hazen KC et al (2001) Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345(23):1660–1666PubMedCrossRef

11.

Kaufman D, Fairchild KD (2004) Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 17(3):638–680, table of contentsPubMedCrossRef

12.

Kaufman DA, Manzoni P (2010) Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol 37(3):611–628PubMedCrossRef

13.

Kicklighter SD, Springer SC, Cox T et al (2001) Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 107(2):293–298PubMedCrossRef

14.

Krasowska A, Murzyn A, Dyjankiewicz A et al (2009) The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Res 9(8):1312–1321PubMedCrossRef

15.

Manzoni P, Farina D, Leonessa M et al (2006) Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118(6):2359–2364PubMedCrossRef

16.

Manzoni P, Jacqz-Aigrain E, Rizzollo S et al (2011) Antifungal prophylaxis in neonates. Early Hum Dev 87(Suppl 1):S59–S60PubMedCrossRef

17.

Manzoni P, Stolfi I, Pugni L et al (2007) A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356(24):2483–2495PubMedCrossRef

18.

Murzyn A, Krasowska A, Augustyniak D et al (2010) The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and Intestin 407. FEMS Microbiol Lett 310(1):17–23PubMedCrossRef

19.

Murzyn A, Krasowska A, Stefanowicz P et al (2010) Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One 5(8):e12050PubMedCrossRef

20.

Ozturk MA, Gunes T, Koklu E et al (2006) Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. Mycoses 49(6):484–492PubMedCrossRef

21.

Romeo MG, Romeo DM, Trovato L et al (2011) Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 31(1):63–69PubMedCrossRef

22.

Samonis G, Falagas ME, Lionakis S et al (2011) Saccharomyces boulardii and Candida albicans experimental colonization of the murine gut. Med Mycol 49(4):395–399PubMedCrossRef

23.

Vandenplas Y, Brunser O, Szajewska H (2009) Saccharomyces boulardii in childhood. Eur J Pediatr 168:253–265PubMedCrossRef

24.

Zwolinska-Wcislo M, Brzozowski T et al (2006) Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 57(Suppl 9):35–49PubMed

Titel: Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants
verfasst von: Gamze Demirel
Istemi Han Celik
Omer Erdeve
Sibel Saygan
Ugur Dilmen
Fuat Emre Canpolat
Publikationsdatum: 01.10.2013
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Pediatrics / Ausgabe 10/2013
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-013-2041-4

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants

Abstract